Sale!

SLC12A2 Gene Bartter Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The SLC12A2 Gene Bartter Syndrome NGS Genetic DNA Test is a cutting-edge genetic diagnostic tool that identifies mutations in the SLC12A2 gene responsible for Bartter syndrome type 1. This comprehensive test utilizes Next-Generation Sequencing (NGS) technology to provide accurate detection of genetic variations affecting kidney function and electrolyte balance. Patients experiencing symptoms like excessive urination, salt cravings, muscle weakness, or growth delays should consider this test for definitive diagnosis. The test offers crucial benefits including precise diagnosis, personalized treatment planning, genetic counseling guidance, and family risk assessment. At only $500 USD, this advanced genetic testing provides valuable insights for managing complex kidney and electrolyte disorders affecting multiple organ systems.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

SLC12A2 Gene Bartter Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Kidney and Electrolyte Disorders

The SLC12A2 Gene Bartter Syndrome NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for complex renal and electrolyte disorders. This advanced test specifically targets mutations in the SLC12A2 gene, which encodes the sodium-potassium-chloride cotransporter NKCC2, a critical protein responsible for salt reabsorption in the kidney’s thick ascending limb of Henle.

What Does This Test Measure and Detect?

Our comprehensive NGS-based genetic test meticulously analyzes the entire coding region of the SLC12A2 gene to identify:

  • Pathogenic mutations causing Bartter syndrome type 1
  • Missense, nonsense, frameshift, and splice-site variants
  • Copy number variations and large deletions
  • Novel genetic alterations affecting protein function
  • Inheritance patterns for genetic counseling purposes

Who Should Consider This Genetic Test?

This specialized genetic test is recommended for individuals presenting with symptoms suggestive of Bartter syndrome or related electrolyte disorders:

  • Infants and children with failure to thrive and growth retardation
  • Patients with polyuria (excessive urination) and polydipsia (excessive thirst)
  • Individuals experiencing salt cravings and electrolyte imbalances
  • Those with hypokalemic metabolic alkalosis
  • Patients with muscle weakness, cramps, or tetany
  • Individuals with a family history of kidney disorders or electrolyte abnormalities
  • Unexplained cases of nephrocalcinosis or kidney stones

Key Benefits of SLC12A2 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous clinical advantages:

  • Definitive Diagnosis: Confirms or rules out Bartter syndrome type 1 with high accuracy
  • Personalized Treatment: Enables targeted therapeutic interventions based on genetic findings
  • Genetic Counseling: Provides essential information for family planning and risk assessment
  • Early Intervention: Facilitates timely management to prevent complications
  • Comprehensive Analysis: NGS technology ensures thorough examination of the entire gene
  • Multi-Specialty Relevance: Results impact management across hepatology, nephrology, and endocrinology

Understanding Your Test Results

Our genetic specialists provide comprehensive interpretation of your results:

  • Positive Result: Indicates the presence of pathogenic mutations in the SLC12A2 gene, confirming Bartter syndrome type 1 diagnosis
  • Negative Result: Suggests absence of detectable mutations in the SLC12A2 gene, though other genetic causes should be considered
  • Variant of Uncertain Significance: Identifies genetic changes with unclear clinical implications requiring further evaluation
  • Carrier Status: Determines if individuals carry one copy of a mutated gene without showing symptoms

All results include detailed clinical correlations and recommendations for follow-up care with appropriate specialists.

Test Information and Pricing

Test Parameter Details
Test Name SLC12A2 Gene Bartter Syndrome NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS) Technology
Specialties Involved General Physician, Genetics, Hepatology, Nephrology, Endocrinology

Pre-Test Requirements

To ensure optimal testing outcomes, we recommend:

  • Complete clinical history documentation
  • Genetic counseling session prior to testing
  • Development of detailed family pedigree chart
  • Discussion of testing implications and potential outcomes
  • Informed consent process

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified collection centers ensures accessible testing for patients nationwide.

Take Control of Your Health Today

Don’t let unexplained symptoms or family history concerns go unaddressed. Our SLC12A2 Gene Bartter Syndrome NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management of complex kidney and electrolyte disorders. With our discounted price of only $500 USD, advanced genetic testing is more accessible than ever.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take the first step toward definitive answers and personalized care.

Our team of genetic specialists and healthcare professionals is ready to guide you through the testing process, answer your questions, and provide the comprehensive support you need for your genetic health journey.